Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.55 |
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | CDC25B | P30305 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | GABRP | O00591 | 2/20 | 0.52 |
| ▸ | GABRD | O14764 | 2/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.52 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.52 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.52 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.52 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6402031 | 0.90 | SMN1; SMN2 (0.63) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL11903896 | 0.89 | NR4A2 (0.60) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL13302221 | 0.84 | NPSR1 (0.72) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL29489280 | 0.83 | GPR84 (0.77) | SMN1; SMN2TP53NPSR1GPR84CNR2 | |
| SCHEMBL8530849 | 0.83 | GPR84 (0.77) | SMN1; SMN2TP53NPSR1GPR84CNR2 | |
| SCHEMBL6331990 | 0.81 | PDGFRB (0.72) | MEN1KMT2APDGFRBPDGFRAFLT3 | |
| SCHEMBL8792509 | 0.80 | SMN1; SMN2 (0.73) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL8534922 | 0.78 | SMN1; SMN2 (1.00) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL27908679 | 0.77 | NR4A2 (0.77) | SMN1; SMN2TP53NPSR1GPR84TUBB1 | |
| SCHEMBL10648347 | 0.76 | CTNNB1 (0.72) | SMN1; SMN2TP53NPSR1GPR84MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CLEMSON UNIVERSITY | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CNR2, CNR1, GPR68 | SMN1; SMN2 3412/4885TP53 1379/4885NPSR1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.